» Articles » PMID: 21448174

Current Misconception 3: That Subgroup-specific Trial Mortality Results Often Provide a Good Basis for Individualising Patient Care

Overview
Journal Br J Cancer
Specialty Oncology
Date 2011 Mar 31
PMID 21448174
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Misconceptions and ill-founded theories can arise in all areas of science. However, the apparent accessibility of many epidemiology findings and popular interest in the subject can lead to additional misunderstandings. The article below is the third in an occasional series of short editorials highlighting some current misinterpretations of epidemiological findings. Invited authors will be given wide scope in judging the prevalence of the misconception under discussion. We hope that this series will prove instructive to cancer researchers in other disciplines as well as to students of epidemiology. Adrian L Harris and Leo Kinlen.

Citing Articles

Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis.

Mauro E, Sanduzzi-Zamparelli M, Sauri T, Soler A, Iserte G, Fortuny M Cancers (Basel). 2024; 16(11).

PMID: 38893196 PMC: 11171222. DOI: 10.3390/cancers16112077.


Iterative Causal Forest: A Novel Algorithm for Subgroup Identification.

Wang T, Keil A, Kim S, Wyss R, Htoo P, Funk M Am J Epidemiol. 2023; 193(5):764-776.

PMID: 37943684 PMC: 11485278. DOI: 10.1093/aje/kwad219.


Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview.

Suh S, Kim S Diabetes Metab J. 2023; 47(5):612-629.

PMID: 37482655 PMC: 10555535. DOI: 10.4093/dmj.2023.0067.


Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time.

Griffin S Diabetologia. 2022; 65(11):1913-1921.

PMID: 35999379 PMC: 9522689. DOI: 10.1007/s00125-022-05782-7.


Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.

Lancet. 2022; 399(10339):1941-1953.

PMID: 35512728 PMC: 9060606. DOI: 10.1016/S0140-6736(22)00519-0.


References
1.
. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365(9472):1687-717. DOI: 10.1016/S0140-6736(05)66544-0. View

2.
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View

3.
. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988; 2(8607):349-60. View

4.
. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT).... Lancet. 1994; 343(8893):311-22. View